New Gastrin Releasing Peptide Receptor-Directed [Tc]Demobesin 1 Mimics: Synthesis and Comparative Evaluation.

Nock, Berthold A; Charalambidis, David; Sallegger, Werner; Waser, Beatrice; Mansi, Rosalba; Nicolas, Guillaume P; Ketani, Eleni; Nikolopoulou, Anastasia; Fani, Melpomeni; Reubi, Jean-Claude; Maina, Theodosia (2018). New Gastrin Releasing Peptide Receptor-Directed [Tc]Demobesin 1 Mimics: Synthesis and Comparative Evaluation. Journal of medicinal chemistry, 61(7), pp. 3138-3150. American Chemical Society 10.1021/acs.jmedchem.8b00177

Text acs.jmedchem.8b00177.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (2MB)

We have previously reported on the gastrin releasing peptide receptor (GRPR) antagonist [Tc]1, ([Tc]demobesin 1, Tc-[N'-diglycolate-dPhe,Leu-NHEt]BBN(6-13)). [Tc]1 has shown superior biological profile compared to analogous agonist-based Tc-radioligands. We herein present a small library of [Tc]1 mimics generated after structural modifications in (a) the linker ([Tc]2, [Tc]3, [Tc]4), (b) the peptide chain ([Tc]5, [Tc]6), and (c) the C-terminus ([Tc]7 or [Tc]8). The effects of above modifications on the biological properties of analogs were studied in PC-3 cells and tumor-bearing SCID mice. All analogs showed subnanomolar affinity for the human GRPR, while most receptor-affine 4 and 8 behaved as potent GRPR antagonists in a functional internalization assay. In mice bearing PC-3 tumors, [Tc]1-[Tc]6 exhibited GRPR-specific tumor uptake, rapidly clearing from normal tissues. [Tc]4 displayed the highest tumor uptake (28.8 ± 4.1%ID/g at 1 h pi), which remained high even after 24 h pi (16.3 ± 1.8%ID/g), well surpassing that of [Tc]1 (5.4 ± 0.7%ID/g at 24 h pi).

Interest & Impact

Downloads

1 since deposited on 04 Dec 2018
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item